{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:31:51Z","timestamp":1793410311868,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI143748"],"award-info":[{"award-number":["R01AI143748"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R00AI151094"],"award-info":[{"award-number":["5R00AI151094"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F31AI183564"],"award-info":[{"award-number":["F31AI183564"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Post-tuberculosis lung disease is a well-recognized sequela of pulmonary tuberculosis (PTB). Extra-PTB (EPTB) accounts for a quarter of the global TB burden; yet pulmonary sequelae in people treated for EPTB are unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed spirometry at successful treatment completion and semi-annually thereafter for 1.5\u2009years, among adults (aged 18\u2009years and older) with drug-sensitive PTB and EPTB recruited from outpatient clinics in India. Adult household contacts without current TB disease underwent spirometry at enrollment and served as non-TB controls. Logistic and linear regression was used to measure the association of treated EPTB with ventilatory defects and persistence of impaired lung function during posttreatment follow-up, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We enrolled 775 TB survivors; 275 (35%) of whom were treated for EPTB and 502 non-TB controls. Compared to controls, EPTB was associated with lower z scores for FEV1 (-0.37; 95% CI, -0.54 to -0.20; P\u2009&amp;lt;\u2009.001) and FVC (-0.46; 95% CI, -0.65 to -0.26; P\u2009&amp;lt;\u2009.001) and higher odds of airflow obstruction (adjusted odds ratio [aOR]\u2009=\u20091.58; 95% CI, 0.95-2.61; P\u2009=\u2009.066) and restrictive spirometry (aOR\u2009=\u20092.16; 95% CI, 1.48-3.15; P\u2009&amp;lt;\u2009.001) at treatment completion. Lung function deficits in EPTB survivors persisted during the 1.5\u2009years of posttreatment follow-up and were associated with respiratory symptoms. Findings were consistent in sensitivity analyses accounting for misclassified EPTB and unmeasured confounders. Ventilatory defects in treated EPTB were phenotypically comparable to those seen in treated PTB, however their burden, severity, and likelihood of respiratory symptoms were lower.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>People treated for EPTB have persistent ventilatory defects and respiratory symptoms and should be screened for post-TB lung disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajrccm\/aamag107","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:50:40Z","timestamp":1772628640000},"page":"1806-1814","source":"Crossref","is-referenced-by-count":3,"title":["Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis"],"prefix":"10.1093","volume":"212","author":[{"given":"Emily","family":"McNair","sequence":"first","affiliation":[{"name":"International Health, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahanara","family":"Valawalkar","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases in India, Johns Hopkins India , Pune, Maharashtra,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samyra R","family":"Cox","sequence":"additional","affiliation":[{"name":"International Health, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Kadam","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases in India, Johns Hopkins India , Pune, Maharashtra,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Lele","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases in India, Johns Hopkins India , Pune, Maharashtra,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Gupte","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases in India, Johns Hopkins India , Pune, Maharashtra,","place":["India"]},{"name":"Infectious Diseases, Johns Hopkins School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusudan","family":"Barthwal","sequence":"additional","affiliation":[{"name":"Hospital and Research Centre, Medicine, Dr. D.Y. Patil Medical College , Pune, Maharashtra,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3847-010X","authenticated-orcid":false,"given":"Arjunlal","family":"Kakrani","sequence":"additional","affiliation":[{"name":"Hospital and Research Centre, Medicine, Dr. D.Y. Patil Medical College , Pune, Maharashtra,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8509-4517","authenticated-orcid":false,"given":"Vidya","family":"Mave","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases in India, Johns Hopkins India , Pune, Maharashtra,","place":["India"]},{"name":"Infectious Diseases, Johns Hopkins School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E","family":"Golub","sequence":"additional","affiliation":[{"name":"International Health, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD,","place":["United States"]},{"name":"Infectious Diseases, Johns Hopkins School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay N","family":"Gupte","sequence":"additional","affiliation":[{"name":"Global Health, Boston University School of Public Health , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"2026081813370351900_aamag107-B1","volume-title":"Global TB Report","year":"2024"},{"key":"2026081813370351900_aamag107-B2","doi-asserted-by":"publisher","first-page":"e0226389","DOI":"10.1371\/journal.pone.0226389","article-title":"Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD","volume":"14","author":"Gupte","year":"2019","journal-title":"PLoS One"},{"key":"2026081813370351900_aamag107-B3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0221-2022","article-title":"Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people","volume":"32","author":"Ivanova","year":"2023","journal-title":"Eur Respir Rev"},{"key":"2026081813370351900_aamag107-B4","doi-asserted-by":"publisher","first-page":"101979","DOI":"10.1016\/j.eclinm.2023.101979","article-title":"Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis","volume":"59","author":"Taylor","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026081813370351900_aamag107-B5","doi-asserted-by":"publisher","first-page":"e0000805","DOI":"10.1371\/journal.pgph.0000805","article-title":"Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: a systematic review and meta-analysis","volume":"2","author":"Maleche-Obimbo","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"2026081813370351900_aamag107-B6","doi-asserted-by":"publisher","first-page":"820","DOI":"10.5588\/ijtld.20.0067","article-title":"Post-tuberculosis lung health: perspectives from the First International Symposium","volume":"24","author":"Allwood","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026081813370351900_aamag107-B7","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1473-3099(19)30309-3","article-title":"Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis","volume":"19","author":"Romanowski","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026081813370351900_aamag107-B8","doi-asserted-by":"publisher","first-page":"e1679","DOI":"10.1016\/S2214-109X(21)00367-3","article-title":"Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae","volume":"9","author":"Menzies","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2026081813370351900_aamag107-B9","doi-asserted-by":"publisher","first-page":"e5080","DOI":"10.1371\/journal.pone.0005080","article-title":"Personal and societal health quality lost to tuberculosis","volume":"4","author":"Miller","year":"2009","journal-title":"PLoS One"},{"key":"2026081813370351900_aamag107-B10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"2026081813370351900_aamag107-B11","doi-asserted-by":"publisher","first-page":"1901959","DOI":"10.1183\/13993003.01959-2019","article-title":"PET\/CT features of extrapulmonary tuberculosis at first clinical presentation: a cross-sectional observational 18F-FDG imaging study across six countries","volume":"55","author":"Bomanji","year":"2020","journal-title":"Eur Respir J"},{"key":"2026081813370351900_aamag107-B12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fimmu.2020.00419","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases are potential biomarkers of pulmonary and extra-pulmonary tuberculosis","volume":"11","author":"Kathamuthu","year":"2020","journal-title":"Front Immunol"},{"key":"2026081813370351900_aamag107-B13","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00390-2020","article-title":"Higher interleukin-6 levels and changes in transforming growth factor-beta are associated with lung impairment in pulmonary tuberculosis","volume":"7","author":"Gupte","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026081813370351900_aamag107-B14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad232","article-title":"Circulating biomarkers, FeNO, and lung function in patients with HIV and tuberculosis","author":"Maenetje","year":"2023","journal-title":"J Infect Dis"},{"key":"2026081813370351900_aamag107-B15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S1473-3099(20)30919-1","article-title":"Quantifying the global number of tuberculosis survivors: a modelling study","volume":"21","author":"Dodd","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2026081813370351900_aamag107-B16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.5588\/ijtld.22.0075","article-title":"A scoping review of interventions to mitigate common non-communicable diseases among people with TB","volume":"26","author":"Romanowski","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026081813370351900_aamag107-B17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.5588\/ijtld.21.0425","article-title":"Clinical standards for the assessment, management and rehabilitation of post-TB lung disease","volume":"25","author":"Migliori","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026081813370351900_aamag107-B18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s13063-022-06503-6","article-title":"Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts","volume":"23","author":"Cox","year":"2022","journal-title":"Trials"},{"key":"2026081813370351900_aamag107-B19","volume-title":"Technical Operational Guidelines Case Finding and Diagnosis Strategy","year":"2020"},{"key":"2026081813370351900_aamag107-B20","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026081813370351900_aamag107-B21","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1164\/rccm.202205-0963OC","article-title":"Race-neutral approach to the interpretation of lung function measurements","volume":"207","author":"Bowerman","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026081813370351900_aamag107-B22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60.","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"2026081813370351900_aamag107-B23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/thoraxjnl-2019-213808","article-title":"Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study","volume":"75","author":"Meghji","year":"2020","journal-title":"Thorax"},{"key":"2026081813370351900_aamag107-B24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/thoraxjnl-2021-217190","article-title":"Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study","volume":"77","author":"Nightingale","year":"2022","journal-title":"Thorax"},{"key":"2026081813370351900_aamag107-B25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5588\/ijtld.21.0501","article-title":"Concomitant pulmonary disease is common among patients with extrapulmonary TB","volume":"26","author":"Shivakumar","year":"2022","journal-title":"Int J Tuberc Lung Dis In"},{"key":"2026081813370351900_aamag107-B26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02129-2019","article-title":"Normal spirometry predictive values for the Western Indian adult population","volume":"56.","author":"Agarwal","year":"2020","journal-title":"Eur Respir J"},{"key":"2026081813370351900_aamag107-B27","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4103\/lungindia.lungindia_159_21","article-title":"Prevalence of chronic obstructive pulmonary disease in India: a systematic review and meta-analysis","volume":"38","author":"Daniel","year":"2021","journal-title":"Lung India"},{"key":"2026081813370351900_aamag107-B28","doi-asserted-by":"publisher","first-page":"04038","DOI":"10.7189\/jogh.11.04038","article-title":"Prevalence of COPD among population above 30 years in India: a systematic review and meta-analysis","volume":"11","author":"Verma","year":"2021","journal-title":"J Glob Health"},{"key":"2026081813370351900_aamag107-B29","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026081813370351900_aamag107-B30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.chest.2025.05.055","article-title":"Contribution of key comorbidities to unfavorable treatment outcomes among adults with drug-sensitive pulmonary TB in India: a prospective cohort \u00adanalysis","volume":"169","author":"Sinha","year":"2026","journal-title":"Chest"},{"key":"2026081813370351900_aamag107-B31","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/cid\/ciac915","article-title":"Impact of undernutrition on tuberculosis treatment outcomes in India: a multicenter prospective cohort analysis","volume":"76","author":"Sinha","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026081813370351900_aamag107-B32","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.2147\/COPD.S378247","article-title":"The relationship between BMI and lung function in populations with different characteristics: a cross-sectional study based on the enjoying breathing program in China","volume":"17","author":"Tang","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026081813370351900_aamag107-B33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/thoraxjnl-2020-215338","article-title":"The long term effect of pulmonary tuberculosis on income and employment in a low income, urban setting","volume":"76","author":"Meghji","year":"2021","journal-title":"Thorax"},{"key":"2026081813370351900_aamag107-B34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1473-3099(13)70015-X","article-title":"Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts","volume":"13","author":"Marais","year":"2013","journal-title":"Lancet Infect Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/advance-article-pdf\/doi\/10.1093\/ajrccm\/aamag107\/68281192\/aamag107.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/212\/8\/1806\/68281192\/aamag107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/212\/8\/1806\/68281192\/aamag107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:37:20Z","timestamp":1787074640000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/212\/8\/1806\/8677660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,5,13]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajrccm\/aamag107","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,5,13]]}}}